Literature DB >> 11221981

Diagnosis and treatment of canine chronic bronchitis. Twenty years of experience.

B C McKiernan1.   

Abstract

Chronic bronchitis is a frustrating disease because the cause is rarely determined, the pathologic changes that accompany and define the disease are usually nonreversible and often progress to life-threatening disorders, and there is a lack of direct scientific evidence for the treatment recommendations that have been offered for the management of this disease in dogs. This article reviews the pathophysiology, clinical presentation, diagnosis, and evaluation of chronic bronchitis in dogs. Important diagnostic tools for use in diagnosis are discussed, including clinical pathology, chest radiographs, and culture and cytology of airway fluid samples.

Entities:  

Mesh:

Year:  2000        PMID: 11221981     DOI: 10.1016/s0195-5616(00)06006-x

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN: 0195-5616            Impact factor:   2.093


  6 in total

1.  Demographic and historical findings, including exposure to environmental tobacco smoke, in dogs with chronic cough.

Authors:  E C Hawkins; L D Clay; J M Bradley; M Davidian
Journal:  J Vet Intern Med       Date:  2010-05-11       Impact factor: 3.333

2.  Antimicrobial use Guidelines for Treatment of Respiratory Tract Disease in Dogs and Cats: Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases.

Authors:  M R Lappin; J Blondeau; D Boothe; E B Breitschwerdt; L Guardabassi; D H Lloyd; M G Papich; S C Rankin; J E Sykes; J Turnidge; J S Weese
Journal:  J Vet Intern Med       Date:  2017-02-10       Impact factor: 3.333

3.  Respiratory dysbiosis and population-wide temporal dynamics in canine chronic bronchitis and non-inflammatory respiratory disease.

Authors:  Aaron C Ericsson; Alexa R Personett; Hansjorg Rindt; Megan E Grobman; Carol R Reinero
Journal:  PLoS One       Date:  2020-01-28       Impact factor: 3.240

4.  Pharmacokinetics of a 503B outsourcing facility-produced theophylline in dogs.

Authors:  Jennifer M Reinhart; Gabriela A R de Oliveira; Lauren Forsythe; Zhong Li
Journal:  PLoS One       Date:  2022-01-06       Impact factor: 3.240

5.  Clinicopathologic features, comorbid diseases, and prevalence of pulmonary hypertension in dogs with bronchomalacia.

Authors:  Jennifer Gamracy; Kelly Wiggen; Aida Vientós-Plotts; Carol Reinero
Journal:  J Vet Intern Med       Date:  2022-02-07       Impact factor: 3.333

6.  Investigation of Neurokinin-1 Receptor Antagonism as a Novel Treatment for Chronic Bronchitis in Dogs.

Authors:  M Grobman; C Reinero
Journal:  J Vet Intern Med       Date:  2016-03-20       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.